Intrinsic Value of S&P & Nasdaq Contact Us

Merit Medical Systems, Inc. MMSI NASDAQ

NASDAQ Global Select • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
70/100
3/7 Pass
SharesGrow Intrinsic Value
$127.25
+80.4%
Analyst Price Target
$100.67
+42.7%

Merit Medical Systems, Inc. (MMSI) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $70.54. It has a SharesGrow Score of 70/100, indicating a above average investment profile with 3 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of MMSI = $127.25 (+80.4% from the current price, the stock appears undervalued). Analyst consensus target is MMSI = $101 (+42.7% upside).

Valuation: MMSI trades at a trailing Price-to-Earnings (P/E) of 31.4 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 3.58.

Financials: revenue is $1.5B, +9.6%/yr average growth. Net income is $128M, growing at +20.3%/yr. Net profit margin is 8.5% (thin). Gross margin is 48.7% (+3.6 pp trend).

Balance sheet: total debt is $898M against $1.6B equity (Debt-to-Equity (D/E) ratio 0.57, moderate). Current ratio is 4.34 (strong liquidity). Debt-to-assets is 33.4%. Total assets: $2.7B.

Analyst outlook: 10 / 13 analysts rate MMSI as buy (77%) — strong consensus.

SharesGrow 7-Criteria breakdown: Value 40/100 (Partial), Growth 83/100 (Pass), Past 100/100 (Pass), Health 67/100 (Partial), Moat 67/100 (Partial), Future 85/100 (Pass), Income 45/100 (Partial).

$100.67
▲ 42.71% Upside
Average Price Target
Based on 13 Wall Street analysts offering 12-month price targets for Merit Medical Systems, Inc., the average price target is $100.67, with a high forecast of $108.00, and a low forecast of $78.00.
Highest Price Target
$108.00
Average Price Target
$100.67
Lowest Price Target
$78.00

MMSI SharesGrow Score Overview

70/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 40/100
Valuation — P/E, PEG, Forward PEG
GROWTH 83/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 67/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 67/100
Gross margin is + market cap
FUTURE 85/100
Analyst outlook — as buy
INCOME 45/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — MMSI

~
VALUE Partial
40/100
MMSI trades at a trailing Price-to-Earnings (P/E) of 31.4 (S&P 500 average ~25). Forward PEG 3.58 — overvalued. Trailing PEG 3.95. Analyst consensus target is $101, implying +43.2% from the current price $71. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
GROWTH Pass
83/100
MMSI: +9.6%/yr revenue is, +20.3%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
PAST Pass
100/100
MMSI: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
~
HEALTH Partial
67/100
Balance sheet MMSI: Debt-to-Equity (D/E) ratio 0.57 (moderate), Current ratio is 4.34 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
67/100
MMSI: Gross margin is 48.7% (+3.6 pp trend), $4B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 67/100. ≥ 70 = Pass.
View details →
FUTURE Pass
85/100
Analyst outlook: 10 / 13 analysts rate MMSI as buy (77%). Analyst consensus target is $101 (+43.2% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
~
INCOME Partial
45/100
MMSI: Net profit margin is 8.5%. thin (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range66.34-100.19
Volume554.41K
Avg Volume (30D)752.88K
Market Cap$4.19B
Beta (1Y)0.65
Share Statistics
EPS (TTM)2.17
Shares Outstanding$59.16M
IPO Date1990-05-14
Employees7,400
CEONeil W. Peterson
Financial Highlights & Ratios
Revenue (TTM)$1.52B
Gross Profit$738.27M
EBITDA$332.05M
Net Income$128.49M
Operating Income$184.72M
Total Cash$448.5M
Total Debt$898.23M
Net Debt$449.73M
Total Assets$2.69B
Price / Earnings (P/E)32.5
Price / Sales (P/S)2.77
Analyst Forecast
1Y Price Target$106.00
Target High$108.00
Target Low$78.00
Upside+50.3%
Rating ConsensusBuy
Analysts Covering13
Buy 77% Hold 15% Sell 8%
Price Target Summary
Company Info
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS5898891040

Price Chart

MMSI
Merit Medical Systems, Inc.  ·  NASDAQ Global Select
Healthcare • Medical - Instruments & Supplies
66.34 52WK RANGE 100.19
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message